PhenomeX Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 285

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108M

  • Investors
  • 2

PhenomeX General Information

Description

PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.

Contact Information

Formerly Known As
Berkeley Lights, Inc., Berkeley Lights, Incorporated, The Beacon, The Culture Station, The Lightening, Berkeley Light, Berkeley Lights, Incorporation
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 5980 Horton Street
  • Second Floor
  • Emeryville, CA 94608
  • United States
+1 (475) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhenomeX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 02-Oct-2023 $108M 00000 00000 Completed Generating Revenue/Not Profitable
11. Secondary Transaction - Open Market 19-Nov-2020 00000 00000 Completed Generating Revenue
10. IPO 17-Jul-2020 00000 00000 00.000 Completed Generating Revenue
9. Later Stage VC 01-Jan-2019 00000 Completed Generating Revenue
8. Later Stage VC (Series E) 28-Jun-2018 0000 00000 00000 Completed Generating Revenue
7. Debt - General 23-May-2018 0000 00000 Completed Generating Revenue
6. Later Stage VC (Series D) 08-Nov-2016 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 21-Sep-2015 000.00 000.00 00000 Completed Generating Revenue
4. Early Stage VC 21-Apr-2014 $4.68M Completed Generating Revenue
3. Early Stage VC (Series A2) 21-Aug-2012 $4M $4.68M 000 Completed Startup
To view PhenomeX’s complete valuation and funding history, request access »

PhenomeX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 3,000,002 $0.000050 8% $0.17 $0.17 1x $0.17 2.63%
Series A 7,320,000 $0.000050 8% $0.03 $0.03 1x $0.03 6.42%
To view PhenomeX’s complete cap table history, request access »

PhenomeX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insi
Drug Discovery
Emeryville, CA
285 As of 2022
00000
00000 0000-00-00
000000&0 00000

000000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000 000000000
Branford, CT
00 As of 0000
000.00
00000000 000.00

000000

e cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000000
Richmond, CA
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PhenomeX Competitors (74)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Azitra Formerly VC-backed Branford, CT 00 000.00 00000000 000.00
ProMab Biotechnologies Corporate Backed or Acquired Richmond, CA 000000000 -
AbCellera Formerly VC-backed Vancouver, Canada 000 00000 00000000 00000
BioLegend Corporate Backed or Acquired San Diego, CA 000 000000&0
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 000000000 00 00000
You’re viewing 5 of 74 competitors. Get the full list »

PhenomeX Executive Team (27)

Name Title Board Seat Contact Info
Siddhartha Kadia Ph.D Chief Executive Officer & Board Member
Keith Breinlinger Ph.D Chief Technology Officer
Rolando Brawer Ph.D Chief Business Officer
Eric Hobbs Ph.D Executive Vice President
Ming Wu Ph.D Co-Founder & Board Member
You’re viewing 5 of 27 executive team members. Get the full list »

PhenomeX Board Members (13)

Name Representing Role Since
John Gunn Self Board Member 000 0000
Makoto Shintani Self Board Member 000 0000
Ming Wu Ph.D PhenomeX Co-Founder & Board Member 000 0000
Siddhartha Kadia Ph.D PhenomeX Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 13 board members. Get the full list »

PhenomeX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhenomeX Former Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
A&E Investments Venture Capital Minority 000 0000 000000 0
AME Cloud Ventures Venture Capital Minority 000 0000 000000 0
Atinum Investment Venture Capital Minority 000 0000 000000 0
Black Diamond Ventures Venture Capital Minority 000 0000 000000 0
Bridger Holdings Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »

PhenomeX Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IsoPlexis 21-Mar-2023 0000000000 000.00 Discovery Tools (Healthcare) 000000000
Optera Therapeutics 07-Mar-2018 Joint Venture Biotechnology 0000 0000
To view PhenomeX’s complete investments and acquisitions history, request access »

PhenomeX Subsidiaries (1)

Company Name Industry Location Founded
IsoPlexis Discovery Tools (Healthcare) Branford, CT 0000
To view PhenomeX’s complete subsidiaries history, request access »

PhenomeX Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Optera Therapeutics 07-Mar-2018 00000 0000000 Completed
  • 2 buyers
To view PhenomeX’s complete exits history, request access »

PhenomeX FAQs

  • When was PhenomeX founded?

    PhenomeX was founded in 2011.

  • Who is the founder of PhenomeX?

    Ming Wu Ph.D is the founder of PhenomeX.

  • Who is the CEO of PhenomeX?

    Siddhartha Kadia Ph.D is the CEO of PhenomeX.

  • Where is PhenomeX headquartered?

    PhenomeX is headquartered in Emeryville, CA.

  • What is the size of PhenomeX?

    PhenomeX has 285 total employees.

  • What industry is PhenomeX in?

    PhenomeX’s primary industry is Drug Discovery.

  • Is PhenomeX a private or public company?

    PhenomeX is a Private company.

  • What is the current valuation of PhenomeX?

    The current valuation of PhenomeX is 00000.

  • What is PhenomeX’s current revenue?

    The current revenue for PhenomeX is 00000.

  • How much funding has PhenomeX raised over time?

    PhenomeX has raised $394M.

  • Who are PhenomeX’s investors?

    A&E Investments, AME Cloud Ventures, Atinum Investment, Black Diamond Ventures, and Bridger Holdings are 5 of 23 investors who have invested in PhenomeX.

  • Who are PhenomeX’s competitors?

    Azitra, ProMab Biotechnologies, AbCellera, BioLegend, and Vedanta Biosciences are some of the 74 competitors of PhenomeX.

  • When was PhenomeX acquired?

    PhenomeX was acquired on 02-Oct-2023.

  • Who acquired PhenomeX?

    PhenomeX was acquired by Bruker.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »